ArticleScientific reports2026
Polyaniline-integrated composite hydrogel network with antioxidant defense, bacterial clearance and In vivo tissue regeneration.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Despite substantial progress, developing wound dressing that simultaneously address infection, oxidative stress, and tissue regeneration remains an active area of research. To address these concerns, we report the development of semi-interpenetrating hydrogel network comprised of polyacrylamide and chitosan, synthesized via a one-pot free radical polymerization. To enhance the therapeutic efficacy, hydrogel was loaded with polyaniline and retinyl palmitate. The developed hydrogel displayed excellent applicability, enabling easy administration at irregular wound sites. In vitro characterization confirmed hydrophilic nature and ability to scavenge reactive nitrogen species (> 90%), promoted cellular activity (L929 cells and red blood cells (< 5%)), mitigates infection risk (kills over 94% and 87% of the Staphylococcus aureus and Escherichia coli bacterial population respectively), prevents biofilm formation, thereby offering a favorable microenvironment for rapid healing. Furthermore, in a rat full-thickness excisional wound model, the developed hydrogel markedly accelerated wound contraction (98.6%), epithelial closure, and collagen deposition (0.8 µg/mg). Overall, this multifunctional polyaniline/retinyl palmitate-integrated hydrogel offers a promising step forward in the development of advanced biomaterials for next generation wound care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.